• Home
  • Study Details
By physician referral or invitation only

A clinical trial looking at the safety and efficacy of an injectable asthma medication called Tezepelumab in 5 to < 12 Year Old Children with Severe Uncontrolled Asthma

We are doing this study to learn more about a drug called tezepelumab (referred to as the "study drug"), when given to children aged 5 to less than 12 years old. The study will look at the effect the study drug has on your child's asthma symptoms and will also determine how safe the study drug is when given to children. The study will also be used to better understand asthma and other associated health problems in children.

Age & Gender

  • 5 years ~ 11 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Michelle Hernandez
Pediatrics - Children's Research Institute

Study Type

Clinical or Medical
Interventional

Study Topics

Lungs and Breathing

IRB Number

23-1438

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research